493 related articles for article (PubMed ID: 25216036)
1. Covalent functionalization of graphene oxide with biocompatible poly(ethylene glycol) for delivery of paclitaxel.
Xu Z; Wang S; Li Y; Wang M; Shi P; Huang X
ACS Appl Mater Interfaces; 2014 Oct; 6(19):17268-76. PubMed ID: 25216036
[TBL] [Abstract][Full Text] [Related]
2. Delivery of paclitaxel using PEGylated graphene oxide as a nanocarrier.
Xu Z; Zhu S; Wang M; Li Y; Shi P; Huang X
ACS Appl Mater Interfaces; 2015 Jan; 7(2):1355-63. PubMed ID: 25546399
[TBL] [Abstract][Full Text] [Related]
3. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
4. Delivery of Oridonin and Methotrexate via PEGylated Graphene Oxide.
Chai D; Hao B; Hu R; Zhang F; Yan J; Sun Y; Huang X; Zhang Q; Jiang H
ACS Appl Mater Interfaces; 2019 Jul; 11(26):22915-22924. PubMed ID: 31252460
[TBL] [Abstract][Full Text] [Related]
5. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel.
Xu H; Fan M; Elhissi AM; Zhang Z; Wan KW; Ahmed W; Phoenix DA; Sun X
Nanomedicine (Lond); 2015; 10(8):1247-62. PubMed ID: 25955123
[TBL] [Abstract][Full Text] [Related]
6. Poly(N-vinyl caprolactam) grown on nanographene oxide as an effective nanocargo for drug delivery.
Kavitha T; Kang IK; Park SY
Colloids Surf B Biointerfaces; 2014 Mar; 115():37-45. PubMed ID: 24316754
[TBL] [Abstract][Full Text] [Related]
7. Improved In Vitro and In Vivo Biocompatibility of Graphene Oxide through Surface Modification: Poly(Acrylic Acid)-Functionalization is Superior to PEGylation.
Xu M; Zhu J; Wang F; Xiong Y; Wu Y; Wang Q; Weng J; Zhang Z; Chen W; Liu S
ACS Nano; 2016 Mar; 10(3):3267-81. PubMed ID: 26855010
[TBL] [Abstract][Full Text] [Related]
8. Chitosan-functionalized graphene oxide as a nanocarrier for drug and gene delivery.
Bao H; Pan Y; Ping Y; Sahoo NG; Wu T; Li L; Li J; Gan LH
Small; 2011 Jun; 7(11):1569-78. PubMed ID: 21538871
[TBL] [Abstract][Full Text] [Related]
9. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
[TBL] [Abstract][Full Text] [Related]
10. Graphene oxide nanosheets conjugated PEG-Glu-Lys-Glu copolymer drug delivery system improves drug-loading rates and enables reduction-sensitive drug release and drug tracking.
Xu Q; Chen H; Zhu J; Li X; Yang J; Deng X; Yuan Q
J Biomater Sci Polym Ed; 2024 Feb; 35(3):330-344. PubMed ID: 38032009
[TBL] [Abstract][Full Text] [Related]
11. Polyethylene Glycol-Engrafted Graphene Oxide as Biocompatible Materials for Peptide Nucleic Acid Delivery into Cells.
Baek A; Baek YM; Kim HM; Jun BH; Kim DE
Bioconjug Chem; 2018 Feb; 29(2):528-537. PubMed ID: 29376329
[TBL] [Abstract][Full Text] [Related]
12. Transferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cells.
Nag M; Gajbhiye V; Kesharwani P; Jain NK
Colloids Surf B Biointerfaces; 2016 Dec; 148():363-370. PubMed ID: 27632697
[TBL] [Abstract][Full Text] [Related]
13. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
[TBL] [Abstract][Full Text] [Related]
14. Thermosensitive and biodegradable polymeric micelles for paclitaxel delivery.
Soga O; van Nostrum CF; Fens M; Rijcken CJ; Schiffelers RM; Storm G; Hennink WE
J Control Release; 2005 Mar; 103(2):341-53. PubMed ID: 15763618
[TBL] [Abstract][Full Text] [Related]
15. Investigation of graphene-based nanomaterial as nanocarrier for adsorption of paclitaxel anticancer drug: a molecular dynamics simulation study.
Hasanzade Z; Raissi H
J Mol Model; 2017 Feb; 23(2):36. PubMed ID: 28120117
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxicity of PEGylated graphene oxide on lymphoma cells.
Du L; Wu S; Li Y; Zhao X; Ju X; Wang Y
Biomed Mater Eng; 2014; 24(6):2135-41. PubMed ID: 25226911
[TBL] [Abstract][Full Text] [Related]
17. Delivery of paclitaxel by physically loading onto poly(ethylene glycol) (PEG)-graft-carbon nanotubes for potent cancer therapeutics.
Lay CL; Liu HQ; Tan HR; Liu Y
Nanotechnology; 2010 Feb; 21(6):065101. PubMed ID: 20057024
[TBL] [Abstract][Full Text] [Related]
18. Surface coating-dependent cytotoxicity and degradation of graphene derivatives: towards the design of non-toxic, degradable nano-graphene.
Li Y; Feng L; Shi X; Wang X; Yang Y; Yang K; Liu T; Yang G; Liu Z
Small; 2014 Apr; 10(8):1544-54. PubMed ID: 24376215
[TBL] [Abstract][Full Text] [Related]
19. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake.
Zhang H; Peng C; Yang J; Lv M; Liu R; He D; Fan C; Huang Q
ACS Appl Mater Interfaces; 2013 Mar; 5(5):1761-7. PubMed ID: 23402618
[TBL] [Abstract][Full Text] [Related]
20. Targeted Delivery of Docetaxel by Use of Transferrin/Poly(allylamine hydrochloride)-functionalized Graphene Oxide Nanocarrier.
Nasrollahi F; Varshosaz J; Khodadadi AA; Lim S; Jahanian-Najafabadi A
ACS Appl Mater Interfaces; 2016 Jun; 8(21):13282-93. PubMed ID: 27158834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
